Consolidated Statements of Comprehensive Loss - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2015	Jun. 30, 2014	Jun. 30, 2015	Jun. 30, 2014
Net loss	$ (17,158,017)	$ (12,769,492)	$ (36,389,505)	$ (26,599,576)
Available for sale securities - net unrealized loss	1,866	998	537	998
Total other comprehensive loss	1,866	998	537	998
Comprehensive loss	(17,156,151)	(12,768,494)	(36,388,968)	(26,598,578)
Comprehensive loss attributable to noncontrolling interests	(31,757)	(164,474)	(76,349)	(312,502)
Comprehensive loss attributable to Caladrius Biosciences, Inc. common stockholders	$ (17,124,394)	$ (12,604,020)	$ (36,312,619)	$ (26,286,076)